Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;31(7):739-746.
doi: 10.1111/iju.15451. Epub 2024 Mar 12.

Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer

Affiliations

Utility of positive core number on MRI-ultrasound fusion targeted biopsy in combination with PI-RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer

Masaki Kobayashi et al. Int J Urol. 2024 Jul.

Abstract

Objectives: To evaluate the utility of magnetic resonance imaging (MRI) and MRI-ultrasound fusion targeted biopsy (TB) for predicting unexpected extracapsular extension (ECE) in clinically localized prostate cancer (CLPC).

Methods: This study enrolled 89 prostate cancer patients with one or more lesions showing a Prostate Imaging-Reporting and Data System (PI-RADS) score ≥3 but without morphological abnormality in the prostatic capsule on pre-biopsy MRI. All patients underwent TB and systematic biopsy followed by radical prostatectomy (RP). Each lesion was examined by 3-core TB, taking cores from each third of the lesion. The preoperative variables predictive of ECE were explored by referring to RP specimens in the lesion-based analysis.

Results: Overall, 186 lesions, including 81 (43.5%), 73 (39.2%), and 32 (17.2%) with PI-RADS 3, 4, and 5, respectively, were analyzed. One hundred and twenty-two lesions (65.6%) were diagnosed as cancer on TB, and ECE was identified in 33 (17.7%) on the RP specimens. The positive TB core number was ≤2 in 129 lesions (69.4%) and three in 57 lesions (30.6%). On the multivariate analysis, PI-RADS ≥4 (p = 0.049, odds ratio [OR] = 2.39) and three positive cores on TB (p = 0.005, OR = 3.07) were independent predictors of ECE. Lesions with PI-RADS ≥4 and a positive TB core number of 3 had a significantly higher rate of ECE than those with PI-RADS 3 and a positive TB core number ≤2 (37.5% vs. 7.8%, p < 0.001).

Conclusions: Positive TB core number in combination with PI-RADS scores is helpful to predict unexpected ECE in CLPC.

Keywords: MRI‐ultrasound fusion targeted prostate biopsy; PI‐RADS scores; extracapsular extension.

PubMed Disclaimer

Similar articles

Cited by

References

REFERENCES

    1. Moris L, Gandaglia G, Vilaseca A, van den Broeck T, Briers E, de Santis M, et al. Evaluation of oncological outcomes and data quality in studies assessing nerve‐sparing versus non–nerve‐sparing radical prostatectomy in nonmetastatic prostate cancer: a systematic review. Eur Urol Focus. 2022;8:690–700.
    1. Preisser F, Gandaglia G, Arad F, Karakiewicz PI, Bandini M, Pompe RS, et al. Association of neurovascular bundle preservation with oncological outcomes in patients with high‐risk prostate cancer. Prostate Cancer Prostatic Dis. 2021;24:193–201.
    1. Sciarra A, Barentsz J, Bjartell A, Eastham J, Hricak H, Panebianco V, et al. Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. Eur Urol. 2011;59:962–977.
    1. Park BH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, et al. Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy. J Urol. 2014;192:82–88.
    1. Matsuoka Y, Numao N, Saito K, Tanaka H, Kumagai J, Yoshida S, et al. Combination of diffusion‐weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: application in patient selection for hemiablative focal therapy. Eur Urol. 2014;65:186–192.

MeSH terms